2130 related articles for article (PubMed ID: 35489108)
21. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
[TBL] [Abstract][Full Text] [Related]
22. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs.
Qunaibi EA; Helmy M; Basheti I; Sultan I
Elife; 2021 May; 10():. PubMed ID: 34042047
[TBL] [Abstract][Full Text] [Related]
23. Knowledge, attitudes, perceptions, and COVID-19 hesitancy in a large public university in Mexico city during the early vaccination rollout.
Mongua-Rodríguez N; Rodríguez-Álvarez M; De-la-Rosa-Zamboni D; Jiménez-Corona ME; Castañeda-Cediel ML; Miranda-Novales G; Cruz-Pacheco G; Ferreira-Guerrero E; Ferreyra-Reyes L; Delgado-Sánchez G; Martínez-Hernández M; Cruz-Salgado A; Pérez-Padilla R; Ponce-de-León S; García-García L
BMC Public Health; 2022 Oct; 22(1):1853. PubMed ID: 36195873
[TBL] [Abstract][Full Text] [Related]
24. Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review.
McCready JL; Nichol B; Steen M; Unsworth J; Comparcini D; Tomietto M
PLoS One; 2023; 18(4):e0280439. PubMed ID: 37043505
[TBL] [Abstract][Full Text] [Related]
25. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country.
Wong LP; Wong PF; AbuBakar S
Hum Vaccin Immunother; 2020 Jul; 16(7):1511-1520. PubMed ID: 31977285
[TBL] [Abstract][Full Text] [Related]
26. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature.
Majid U; Ahmad M; Zain S; Akande A; Ikhlaq F
Health Promot Int; 2022 Jun; 37(3):. PubMed ID: 35788306
[TBL] [Abstract][Full Text] [Related]
28. A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti.
Wang CW; de Jong EP; Faure JA; Ellington JL; Chen CS; Chan CC
Hum Vaccin Immunother; 2022 Nov; 18(5):2050121. PubMed ID: 35349382
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
[TBL] [Abstract][Full Text] [Related]
30. Cognitive underpinnings of COVID-19 vaccine hesitancy.
Acar-Burkay S; Cristian DC
Soc Sci Med; 2022 May; 301():114911. PubMed ID: 35395612
[TBL] [Abstract][Full Text] [Related]
31. Vaccine hesitancy in the Gulf Cooperation Council countries.
Algabbani A; AlOmeir O; Algabbani F
East Mediterr Health J; 2023 May; 29(5):402-411. PubMed ID: 37306176
[TBL] [Abstract][Full Text] [Related]
32. Barriers affecting COVID‑19 vaccination in Phalombe District, Malawi: A qualitative study.
Chimatiro CS; Hajison P; Jella CD; Tshotetsi L; Mpachika-Mfipa F
S Afr Med J; 2023 Mar; 113(4):e16554. PubMed ID: 37283154
[TBL] [Abstract][Full Text] [Related]
33. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
Hossain MS; Islam MS; Pardhan S; Banik R; Ahmed A; Islam MZ; Mahabub MS; Sikder MT
PLoS One; 2022; 17(8):e0269944. PubMed ID: 35998135
[TBL] [Abstract][Full Text] [Related]
34. Trust of Italian healthcare professionals in COVID-19 (anti-SARS-COV-2) vaccination.
Di Valerio Z; Montalti M; Guaraldi F; Tedesco D; Nreu B; Mannucci E; Monami M; Gori D
Ann Ig; 2022; 34(3):217-226. PubMed ID: 34328496
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the relationship between moral values and vaccine hesitancy in Great Britain during the COVID-19 pandemic: A cross-sectional survey.
Schmidtke KA; Kudrna L; Noufaily A; Stallard N; Skrybant M; Russell S; Clarke A
Soc Sci Med; 2022 Sep; 308():115218. PubMed ID: 35870299
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Vaccine Hesitancy, Acceptance, and Promotion Among Healthcare Workers: A Mixed-Methods Analysis.
Hoffman BL; Boness CL; Chu KH; Wolynn R; Sallowicz L; Mintas D; Douaihy AB; Felter EM; Sidani JE
J Community Health; 2022 Oct; 47(5):750-758. PubMed ID: 35676390
[TBL] [Abstract][Full Text] [Related]
37. Vaccine hesitancy among healthcare professionals and the general population: Second important step in the fight against COVID-19.
Metin S; Eraybar S; Aygun H; Ekinci F
J Infect Dev Ctries; 2023 Feb; 17(2):157-165. PubMed ID: 36897892
[TBL] [Abstract][Full Text] [Related]
38. Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi.
Adeyanju GC; Betsch C; Adamu AA; Gumbi KS; Head MG; Aplogan A; Tall H; Essoh TA
Glob Health Res Policy; 2022 Aug; 7(1):28. PubMed ID: 35978401
[TBL] [Abstract][Full Text] [Related]
39. [Vaccine hesitancy: current status, associated factors, measurement, and approach].
Machida M; Inoue S
Nihon Koshu Eisei Zasshi; 2023 Aug; 70(8):474-482. PubMed ID: 37164752
[TBL] [Abstract][Full Text] [Related]
40. Vaccine hesitancy among people with multiple sclerosis.
Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
